Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

v3.24.3
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Beginning balance, value at Mar. 31, 2023 $ 200,909 $ (189,514) $ (3,418) $ 7,977
Beginning balance, shares at Mar. 31, 2023 246,678        
Cost in connection with ATM (5) (5)
Employee stock-based compensation expenses 177 177
Employee stock-based compensation expenses, shares 10,402        
Foreign currency translation adjustment 511 511
Net loss (1,418) (1,418)
Ending balance, value at Jun. 30, 2023 201,081 (190,932) (2,907) 7,242
Ending balance, shares at Jun. 30, 2023 257,080        
Beginning balance, value at Mar. 31, 2023 200,909 (189,514) (3,418) 7,977
Beginning balance, shares at Mar. 31, 2023 246,678        
Net loss         (2,902)
Ending balance, value at Sep. 30, 2023 201,211 (192,416) (3,120) 5,675
Ending balance, shares at Sep. 30, 2023 258,967        
Beginning balance, value at Jun. 30, 2023 201,081 (190,932) (2,907) 7,242
Beginning balance, shares at Jun. 30, 2023 257,080        
Employee stock-based compensation expenses 130 130
Employee stock-based compensation expenses, shares 1,887        
Foreign currency translation adjustment (213) (213)
Net loss (1,484) (1,484)
Ending balance, value at Sep. 30, 2023 201,211 (192,416) (3,120) 5,675
Ending balance, shares at Sep. 30, 2023 258,967        
Beginning balance, value at Mar. 31, 2024 203,209 (194,349) (2,723) 6,137
Beginning balance, shares at Mar. 31, 2024 780,371        
Proceeds from At-the-Market sale of common stock, net of offering expenses 748 748
Proceeds from At-the-Market sale of common stock, net of offering expenses, shares 158,311        
Proceeds from exercise of employee stock options 7 7
Proceeds from exercise of employee stock options, shares 2,000        
Employee stock-based compensation expenses 107 107
Employee stock-based compensation expenses, shares 9,538        
Foreign currency translation adjustment (881) (881)
Net loss (1,143) (1,143)
Ending balance, value at Jun. 30, 2024 204,071 (195,492) (3,604) 4,975
Ending balance, shares at Jun. 30, 2024 950,220        
Beginning balance, value at Mar. 31, 2024 203,209 (194,349) (2,723) 6,137
Beginning balance, shares at Mar. 31, 2024 780,371        
Net loss         (1,753)
Ending balance, value at Sep. 30, 2024 205,651 (196,102) (4,197) 5,352
Ending balance, shares at Sep. 30, 2024 1,338,615        
Beginning balance, value at Jun. 30, 2024 204,071 (195,492) (3,604) 4,975
Beginning balance, shares at Jun. 30, 2024 950,220        
Proceeds from At-the-Market sale of common stock, net of offering expenses 1,541 1,541
Proceeds from At-the-Market sale of common stock, net of offering expenses, shares 381,433        
Proceeds from exercise of employee stock options 26 26
Proceeds from exercise of employee stock options, shares 7,250        
Payments for fractional shares related to reverse-split (1) (1)
Payments for fractional shares related to reverse-split, shares (288)        
Employee stock-based compensation expenses 14 14
Foreign currency translation adjustment (593) (593)
Net loss (610) (610)
Ending balance, value at Sep. 30, 2024 $ 205,651 $ (196,102) $ (4,197) $ 5,352
Ending balance, shares at Sep. 30, 2024 1,338,615